MetaVia Inc. (MTVA)vsRevolution Medicines Inc (RVMD)
MTVA
MetaVia Inc.
$1.58
-1.11%
HEALTHCARE · Cap: $7.64M
RVMD
Revolution Medicines Inc
$190.46
+0.25%
HEALTHCARE · Cap: $40.39B
Smart Verdict
WallStSmart Research — data-driven comparison
RVMD leads profitability with a 0.0% profit margin vs 0.0%. MTVA earns a higher WallStSmart Score of 26/100 (F).
MTVA
Avoid26
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MTVA
The strongest argument for MTVA centers on Price/Book, Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : MTVA
The primary concerns for MTVA are Revenue Growth, EPS Growth, Market Cap.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
RVMD carries more volatility with a beta of 1.38 — expect wider price swings.
MTVA is growing revenue faster at 0.0% — sustainability is the question.
MTVA generates stronger free cash flow (-4M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MTVA scores higher overall (26/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MetaVia Inc.
HEALTHCARE · BIOTECHNOLOGY · USA
MetaVia Inc. is a forward-thinking technology firm specializing in transformative digital solutions that optimize connectivity and productivity across various sectors. By harnessing state-of-the-art artificial intelligence and cloud computing, MetaVia develops robust, customized platforms designed to address the unique challenges of its clientele. With a strong commitment to sustainability and social responsibility, the company not only meets current market expectations but also fosters long-term growth potential. Positioned strategically to capitalize on evolving trends in the tech industry, MetaVia aims to deliver substantial value to its shareholders while adapting to an ever-changing landscape.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?